NCT05047354View on ClinicalTrials.gov

Biochemical and Phenotypical Aspects of Smith-Lemli-Opitz Syndrome and Related Disorders of Cholesterol Metabolism

RecruitingOBSERVATIONAL
Enrollment

250

Participants

Timeline

Start Date

June 23, 2021

Primary Completion Date

May 31, 2031

Study Completion Date

May 31, 2031

Conditions
Smith Lemli Opitz SyndromeCHILD SyndromeLathosterolosisDesmosterolosis
Trial Locations (1)

20892

RECRUITING

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH